Advertisement

Reactions Weekly

, Volume 1770, Issue 1, pp 316–316 | Cite as

Olaparib

Gout: case report
Case report
  • 11 Downloads

Reference

  1. Matthews Hew T, et al. PARP Inhibitor Olaparib Use in a BRCA1-Positive Patient With Metastatic Triple-Negative Breast Cancer, Without the Initial Use of Platinum-Based Chemotherapy, Showing Significant Rapid Near Resolution of Large Liver Metastasis While Patient Experienced Gout-Like Symptoms. Journal of Investigative Medicine High Impact Case Reports 7: 2019. Available from: URL: http://doi.org/10.1177/2324709619864989 - USA

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations